Hhdpharm Supply Regorafenib Anticancer Inhibitor Raw Material Regorafenib Powder CAS 755037-03-7

• Powder: Yes
• Customized: Non-Customized
• Suitable for: Adult
• Purity: >98%
• Color: White
• Grade: Pharmaceutical Grade
• Model NO.: HHD Pharm
• Transport Package: Alumininum Foli Bags
• Specification: 10g, 50g, 200g, 1kg, 5kg
• Trademark: hhdpharm
• Origin: China

Product Description

Wuhan HHD Supply Regorafenib Anticancer Inhibitor Raw Material Regorafenib Powder CAS 755037-03-7 

 

Basic information:

 

Prodcut name	Regorafenib
Synonyms	4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide;4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;Stivarga®;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;
MOQ	10g
CAS	755037-03-7
Appearance	Powder
Molecular Formula	C21H15ClF4N4O3
Molecular Weight	482.815
Assay	99%
Application	Pharma grade
Packing	As per your request
Storage	Preserve in tight, light-resistant containers in a cool place

Description:

Regorafenib (BAY 73-4506, commercial name Stivarga) is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types.[1] By 2015 it had 2 US approvals for advanced cancers.